Comparative Study Matching Intraperitoneal Onlay Mesh (IPOM) and Sublay Mesh to Treat Umbilical Hernia
This study is currently recruiting participants.
Verified September 2012 by University Hospital, Basel, Switzerland
Sponsor:
University Hospital, Basel, Switzerland
Collaborator:
Clinical Trial Unit, University Hospital Basel, Switzerland
Information provided by (Responsible Party):
University Hospital, Basel, Switzerland
ClinicalTrials.gov Identifier:
NCT01201564
First received: July 19, 2010
Last updated: September 10, 2012
Last verified: September 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
This study is designed to compare two techniques for operative care of umbilical hernia in adults regarding wound complications, wound side fluid collections, recurrence rate, postoperative pain, duration of hospitalization and quality of life. The IPOM technique provides mesh positioning directly into the abdominal cavity onto the defect under laparoscopic control while in sublay position the mesh is placed directly behind the rectus muscle after small incision close to the belly button.
| Condition | Intervention | Phase |
|---|---|---|
|
Umbilical Hernia |
Procedure: intraperitoneal onlay mesh repair Procedure: sublay mesh repair |
Phase 3 |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Safety/Efficacy Study Intervention Model: Parallel Assignment Masking: Open Label Primary Purpose: Treatment |
| Official Title: | Prospective Randomized Multicenter Trial Comparing Laparoscopic (IPOM) vs. Sublay Mesh Plasty for Umbilical Hernia in Adults |
Resource links provided by NLM:
Genetics Home Reference related topics:
abdominal wall defect
MedlinePlus related topics:
Hernia
U.S. FDA Resources
Further study details as provided by University Hospital, Basel, Switzerland:
Primary Outcome Measures:
- early wound complications [ Time Frame: 30 days after operation ] [ Designated as safety issue: No ]
- wound infection (with or without removal of the mesh)
- wound necrosis
- wound hematoma
- late wound complications [ Time Frame: 1 year after operation ] [ Designated as safety issue: No ]
- wound infection (with or without removal of the mesh)
- wound necrosis
- wound hematoma
Secondary Outcome Measures:
- complication rate perioperative [ Time Frame: intraoperative complications will be recorded immediatly after finishing the operation ] [ Designated as safety issue: No ]
- major bleeding
- bowel injury
- duration of operation [ Time Frame: the duration will be recorded immediatly after finishing the operation ] [ Designated as safety issue: No ]measured in minutes according to operations protocol (duration cut - suture)
- hospital stay [ Time Frame: will be measured after discharge of the patient ] [ Designated as safety issue: No ]measured in days
- umbilical hernia recurrence rate [ Time Frame: 30 days ] [ Designated as safety issue: No ]the diagnosis of recurrence will be given by the surgeon clinically or due to ultrasound scan
- umbilical hernia recurrence rate [ Time Frame: 1 year ] [ Designated as safety issue: No ]the diagnosis of recurrence will be given by the surgeon clinically or due to ultrasound scan
- umbilical hernia recurrence rate [ Time Frame: 3 years ] [ Designated as safety issue: No ]the diagnosis of recurrence will be given by the surgeon clinically or due to ultrasound scan
- umbilical hernia recurrence rate [ Time Frame: 5 years ] [ Designated as safety issue: No ]the diagnosis of recurrence will be given by the surgeon clinically or due to ultrasound scan
- navel site seroma [ Time Frame: discharge day ] [ Designated as safety issue: No ]the diagnosis of seroma will be given by the surgeon clinically or by ultrasound scan and measured in ccm (height(cm) x width(cm)x length(cm))
- navel site seroma [ Time Frame: after 30 days ] [ Designated as safety issue: No ]the diagnosis of seroma will be given by the surgeon clinically or by ultrasound scan and measured in ccm (height(cm) x width(cm)x length(cm))
- navel site seroma [ Time Frame: after 1 year ] [ Designated as safety issue: No ]the diagnosis of seroma will be given by the surgeon clinically or by ultrasound scan and measured in ccm (height(cm) x width(cm)x length(cm))
- complication rate postoperative [ Time Frame: 30 day ] [ Designated as safety issue: No ]
- trocar site hernia
- enteral fistula
- persistent pain
- re-operation
- complication rate postoperative [ Time Frame: 1 year ] [ Designated as safety issue: No ]
- trocar site hernia
- enteral fistula
- persistent pain
- re-operation
- complication rate postoperative [ Time Frame: 3 years ] [ Designated as safety issue: No ]
- trocar site hernia
- enteral fistula
- persistent pain
- re-operation
- complication rate postoperative [ Time Frame: 5 years ] [ Designated as safety issue: No ]
- trocar site hernia
- enteral fistula
- persistent pain
- re-operation
- pain score (Visual Analog Scale - VAS) [ Time Frame: 24h post operative ] [ Designated as safety issue: No ]will be measured by the nurse according to Visual Analog Scale
- pain score (Visual Analog Scale - VAS) [ Time Frame: 48h post operative ] [ Designated as safety issue: No ]will be measured by the nurse according to Visual Analog Scale
- pain score (Visual Analog Scale - VAS) [ Time Frame: immediately before discharge ] [ Designated as safety issue: No ]will be measured by the nurse according to Visual Analog Scale
- Quality of life (SF-36) [ Time Frame: 1 day pre-operative ] [ Designated as safety issue: No ]patients will be asked to fulfill validated SF-36 questionnaire
- Quality of life (SF-36) [ Time Frame: 30 days postoperatively ] [ Designated as safety issue: No ]patients will be asked to fulfill validated SF-36 questionnaire
- Quality of life (SF-36) [ Time Frame: 1 year postoperatively ] [ Designated as safety issue: No ]patients will be asked to fulfill validated SF-36 questionnaire
| Estimated Enrollment: | 306 |
| Study Start Date: | July 2010 |
| Estimated Primary Completion Date: | July 2015 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
| Active Comparator: intraperitoneal onlay mesh repair |
Procedure: intraperitoneal onlay mesh repair
The IPOM technique provides mesh positioning directly into the abdominal cavity onto the defect under laparoscopic control while in sublay position the mesh is placed directly behind des rectus muscle after small incision close to the belly button.
|
| Active Comparator: sublay mesh repair |
Procedure: sublay mesh repair
The IPOM technique provides mesh positioning directly into the abdominal cavity onto the defect under laparoscopic control while in sublay position the mesh is placed directly behind des rectus muscle after small incision close to the belly button.
|
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Criteria
Inclusion Criteria:
- informed consent
- patient age: ≥ 18 years
- elective surgery for umbilical hernia
- hernia diameter ≥ 1cm
Exclusion Criteria:
- previous history of median laparotomy
- navel site infection
- contraindication for general anaesthesia
- ASA score >IV
- pregnancy
- cirrhosis of the liver (CHILD B and C) and/or ascites
- cytostatic therapy
- incarcerated hernia
- recurrent hernia
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01201564
Contacts
| Contact: Daniel Oertli, Professor | +41 61 265 ext 7234 | doertli@uhbs.ch |
| Contact: Heizmann Oleg, MD | +41 61 328 ext 6867 | oheizmann@uhbs.ch |
Locations
| Germany | |
| Diakoniekrankenhaus Rotenburg (Wuemme) gGmbH | Not yet recruiting |
| Rotenburg, Niedersachsen, Germany, 27356 | |
| Contact: Oleg Heizmann, MD +49 4261 77 ext 2691 o.heizmann@diako-online.de | |
| Contact: Daniel Matz, MD +49 4261 77 ext 2691 d.matz@diako-online.de | |
| Principal Investigator: Daniel Matz, MD | |
| Principal Investigator: Oleg Heizmann, MD | |
| Poland | |
| Jagiellonian University | Recruiting |
| Cracow, Poland, 31-501 | |
| Contact: Miroslaw Szura, MD, PhD msszura@gmail.com | |
| Contact: Radoslaw Pach, MD, PhD radoslaw.pach@uj.edu.pl | |
| Sub-Investigator: Radoslaw Pach, MD. PhD | |
| Switzerland | |
| University Hospital Basel | Recruiting |
| Basel, Switzerland, 4031 | |
| Contact: Daniel Oertli, Professor +41 61 265 ext 7234 doertli@uhbs.ch | |
| Contact: Henry Hoffmann, MD +41 61 328 ext 7824 hhoffmann@uhbs.ch | |
| Sub-Investigator: Hofmann Henry, MD | |
| Luzerner Kantonsspital | Recruiting |
| Luzern, Switzerland, 6000 | |
| Contact: Jürg Metzger, Professor +41 205 ext 48 62 juerg.metzger@ksl.ch | |
| Contact: Melanie Kauper, MD +41 205 ext 48 62 melanie.kauper@ksl.ch | |
| Principal Investigator: Melanie Kauper, MD | |
| Sub-Investigator: Angela Lemarechal, MD | |
Sponsors and Collaborators
University Hospital, Basel, Switzerland
Clinical Trial Unit, University Hospital Basel, Switzerland
Investigators
| Study Chair: | Daniel Oertli, Professor | Departement of Genral Surgery, University Hospital Basel, Switzerland |
| Study Director: | Oleg Heizmann, MD | Departement of General,- Visceral- and Thoracic Surgery, Diakoniekrankenhaus Rotenburg (Wuemme), Germany |
| Principal Investigator: | Daniel Matz, MD | Departement of General,- Visceral- and Thoracic Surgery, Diakoniekrankenhaus Rotenburg (Wuemme), Germany |
More Information
Publications:
| Responsible Party: | University Hospital, Basel, Switzerland |
| ClinicalTrials.gov Identifier: | NCT01201564 History of Changes |
| Other Study ID Numbers: | IPOM-46/10 |
| Study First Received: | July 19, 2010 |
| Last Updated: | September 10, 2012 |
| Health Authority: | Switzerland: Ethikkommission |
Keywords provided by University Hospital, Basel, Switzerland:
|
umbilical hernia, wound complications, mesh repair, IPOM, |
quality of life, sublay mesh repair, recurrence rate |
Additional relevant MeSH terms:
|
Hernia Hernia, Umbilical Pathological Conditions, Anatomical |
Infant, Newborn, Diseases Hernia, Ventral Hernia, Abdominal |
ClinicalTrials.gov processed this record on June 17, 2013